NCT04722068View on ClinicalTrials.gov

Regeneron 1331 Kinetics Sub-Study HoFH

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 7, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

January 1, 2021

Conditions
Hypercholesterolemia, Familial
Interventions
OTHER

Kinetics test

Subjects will participate in two study visits to evaluate lipoprotein kinetics before and after administration of evinacumab.

Trial Locations (2)

1105

Department of Vascular Medicine Amsterdam UMC, Amsterdam

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT04722068 - Regeneron 1331 Kinetics Sub-Study HoFH | Biotech Hunter | Biotech Hunter